Mabpharm Limited (HKG:2181)

Mabpharm Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 26, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	2,268	2,062	1,155	1,897	1,794	4,124
Market Cap Growth	-8.33%	78.57%	-39.13%	5.75%	-56.50%	-4.76%
Enterprise Value	2,510	2,293	1,337	2,080	1,849	3,803
Last Close Price	0.55	0.50	0.28	0.46	0.43	1.00
PE Ratio	49.42	32.43	-	-	-	-
PS Ratio	3.15	2.87	4.20	19.76	28.38	40.54
PB Ratio	12.96	11.78	12.20	8.40	3.96	5.58
P/TBV Ratio	33.39	30.35	12.20	8.40	3.96	5.58
P/FCF Ratio	-	-	-	44.90	-	-
P/OCF Ratio	-	-	-	30.00	-	-
EV/Sales Ratio	3.49	3.19	4.87	21.66	29.24	37.38
EV/EBITDA Ratio	38.46	35.13	-	-	-	-
EV/EBIT Ratio	-	418.15	-	-	-	-
EV/FCF Ratio	-	-	-	49.23	-	-
Debt / Equity Ratio	2.08	2.08	3.50	1.38	0.43	0.08
Debt / EBITDA Ratio	5.57	5.57	-	-	-	-
Debt / FCF Ratio	-	-	-	7.37	-	-
Net Debt / Equity Ratio	1.38	1.38	2.50	0.53	0.31	-0.06
Net Debt / EBITDA Ratio	3.71	3.71	-3.37	-0.73	-0.67	0.13
Net Debt / FCF Ratio	-	-	-7.35	2.85	-0.67	0.10
Asset Turnover	0.60	0.60	0.25	0.09	0.06	0.08
Inventory Turnover	0.59	0.59	0.37	0.12	0.20	0.39
Quick Ratio	0.50	0.50	0.62	0.69	0.47	0.53
Current Ratio	0.81	0.81	1.17	1.08	1.07	1.05
Return on Equity (ROE)	46.41%	46.41%	-87.04%	-69.09%	-42.04%	-39.33%
Return on Assets (ROA)	0.28%	0.28%	-7.29%	-12.93%	-15.56%	-18.03%
Return on Capital Employed (ROCE)	0.80%	0.80%	-17.00%	-28.10%	-31.00%	-44.70%
Earnings Yield	2.80%	3.08%	-11.79%	-12.16%	-13.29%	-8.68%
FCF Yield	-	-	-2.79%	2.23%	-11.47%	-10.36%
Buyback Yield / Dilution	-38.53%	-38.54%	-	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.